12 results on '"Diallo, Makonon"'
Search Results
2. Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial
3. Genome-wide genetic variation and molecular surveillance of drug resistance in Plasmodium falciparum isolates from asymptomatic individuals in Ouélessébougou, Mali
4. Single low-dose tafenoquine combined with dihydroartemisinin–piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial
5. Pyronaridine–artesunate or dihydroartemisinin–piperaquine combined with single low-dose primaquine to prevent Plasmodium falciparum malaria transmission in Ouélessébougou, Mali: a four-arm, single-blind, phase 2/3, randomised trial
6. Persistence of Plasmodium falciparum HRP-2 antigenaemia after artemisinin combination therapy is not associated with gametocytes
7. Artemether-lumefantrine with or without single-dose primaquine and sulfadoxine-pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2 single-blind randomised clinical trial in Ouelessebougou, Mali
8. Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial
9. Additional file 1 of Persistence of Plasmodium falciparum HRP-2 antigenaemia after artemisinin combination therapy is not associated with gametocytes
10. Persistence of P. falciparum HRP-2 antigenaemia post treatment is not associated with gametocytes
11. Pyronaridine-Artesunate Combined With Low Dose Primaquine for Preventing P. falciparum Malaria Transmission: A Single-Blind Randomized Clinical Trial in Ouelessebougou, Mali
12. Single Low Dose Tafenoquine Combined with Dihydroartemisinin-Piperaquine to Reduce P. Falciparum Transmission: A Phase 2 Single Blind Randomised Clinical Trial in Ouelessebougou, Mali
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.